There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on DENTSPLY SIRONA (XRAY – Research Report) and Oric Pharmaceuticals (ORIC – Research Report) with bullish sentiments.
DENTSPLY SIRONA (XRAY)
Barrington analyst Michael Petusky maintained a Buy rating on DENTSPLY SIRONA today and set a price target of $53.00. The company’s shares closed last Tuesday at $42.20, close to its 52-week low of $41.16.
According to TipRanks.com, Petusky is a 4-star analyst with an average return of
Currently, the analyst consensus on DENTSPLY SIRONA is a Moderate Buy with an average price target of $59.00, a 40.4% upside from current levels. In a report issued on April 5, Evercore ISI also maintained a Buy rating on the stock with a $65.00 price target.
Oric Pharmaceuticals (ORIC)
J.P. Morgan analyst Anupam Rama maintained a Buy rating on Oric Pharmaceuticals yesterday and set a price target of $17.00. The company’s shares closed last Tuesday at $3.86, close to its 52-week low of $3.75.
According to TipRanks.com, Rama has 0 stars on 0-5 stars ranking scale with an average return of
Oric Pharmaceuticals has an analyst consensus of Moderate Buy, with a price target consensus of $12.50, which is a 220.5% upside from current levels. In a report issued on April 4, Citigroup also upgraded the stock to Buy with a $10.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on XRAY:
- Analysts Offer Insights on Utilities Companies: CNX Resources (CNX), Consolidated Edison (ED) and EOG Resources (EOG)
- These Stocks are the Biggest Pre-Market Movers on Wednesday
- Twitter Saga Continues: The Return of the Volatility
- Maxim Group Thinks Elys Game Technology’s Stock is Going to Recover
- 2 Healthcare Stocks Picked Up by Insiders